Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.85M | -6.74M | -7.25M | -7.72M | -8.59M |
| Total Depreciation and Amortization | 159.40K | 181.40K | 196.70K | 199.10K | 217.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -463.10K | -494.20K | -179.50K | -168.90K | 316.90K |
| Change in Net Operating Assets | 817.10K | -84.30K | 243.60K | -420.50K | -1.09M |
| Cash from Operations | -6.34M | -7.13M | -6.99M | -8.11M | -9.15M |
| Capital Expenditure | -1.10K | -1.30K | -271.30K | -306.70K | -393.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.10K | -1.30K | -271.30K | -306.70K | -393.50K |
| Total Debt Issued | 0.00 | 0.00 | 2.00M | 2.00M | 2.00M |
| Total Debt Repaid | 283.40K | 136.00K | -1.72M | -1.72M | -2.00M |
| Issuance of Common Stock | 3.85M | 3.85M | 8.57M | 12.07M | 12.07M |
| Repurchase of Common Stock | -400.00 | -400.00 | -400.00 | -400.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -464.70K | -464.70K | -1.13M | -1.84M | -1.85M |
| Cash from Financing | 3.67M | 3.52M | 7.72M | 10.51M | 10.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.67M | -3.62M | 454.90K | 2.09M | 678.80K |